Recent studies indicate that a deficiency in anti-inflammatory cytokines, particularly transforming growth factor-β1 (TGF-β1), in the brains of patients with AD significantly contributes to microglia activation and neuroinflammation, thereby playing a crucial role in the pathophysiological mechanisms underlying cognitive decline in AD. The gene discussed is TGFB1; the disease is Alzheimer disease.